U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H8O2
Molecular Weight 100.1158
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLUTARAL

SMILES

O=CCCCC=O

InChI

InChIKey=SXRSQZLOMIGNAQ-UHFFFAOYSA-N
InChI=1S/C5H8O2/c6-4-2-1-3-5-7/h4-5H,1-3H2

HIDE SMILES / InChI

Molecular Formula C5H8O2
Molecular Weight 100.1158
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Glutaraldehyde is marketed by The Dow Chemical Company under several trade names in a wide range of applications from leather tanning, photography, paper, water treatment, and high level disinfection of medical instrumentation to animal husbandry. Biocide, glutaraldehyde, is widely used in products for disinfection, sanitisation, preservation and slimicidal application in industry, hospitals and on farms. Products based on glutaraldehyde are effective against Gram positive and Gram negative bacteria, fungi, and a variety of viruses (including infectious bursal disease, porcine reproductive and respiratory syndrome virus, hog cholera virus, human corona virus. Glutaraldehyde is toxic and a strong irritant

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Polyaniline-dacron composite as solid phase in enzyme linked immunosorbent assay for Yersinia pestis antibody detection.
2001-08
Chemical synthesis of cross-linked poly(KGGVG), an elastin-like biopolymer.
2001-07
Hydrolysis of rice hull by crosslinked Aspergillus niger cellulase.
2001-07
Diamine extension of glutaraldehyde crosslinks mitigates bioprosthetic aortic wall calcification in the sheep model.
2001-07
Calcification resistance, biostability, and low immunogenic potential of porcine heart valves modified by dye-mediated photooxidation.
2001-07
Competitive sorption of platinum and palladium on chitosan derivatives.
2001-06-12
The combined effect of IDA and glutaraldehyde on the properties of human erythrocytes.
2001-06-04
A simple and highly efficient fixation method for Chrysochromulina polylepis (Prymnesiophytes) for analytical flow cytometry.
2001-06-01
Antigenicity of cryopreserved arterial allografts: comparison with fresh and glutaraldehyde treated grafts.
2001-05-26
Evaluation of acellular dermal graft (AlloDerm) sheet for soft tissue augmentation: a 1-year follow-up of clinical observations and histological findings.
2001-05-23
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope.
2001-05-17
Enhanced resolution of membranes in cultured cells by cryoimmobilization and freeze-substitution.
2001-05-15
Garlic prevents ultrastructural alterations caused by dehydration in mouse cerebral microvessels.
2001-05-01
Conformationally specific misfolding of an integral membrane protein.
2001-05-01
Identification and characterization of membrane estrogen receptor from MCF7 estrogen-target cells.
2001-05
Factor XIII of blood coagulation as a nuclear crosslinking enzyme.
2001-05
Electron microscopic assessment of smeared or imprinted specimens of solid tumours.
2001-05
Effects of processing conditions on the rheological behavior of collagen dispersions.
2001-05
Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system.
2001-05
Diagnosis by intraoperative transesophageal echocardiography of acute thrombosis of mechanical aortic valve prosthesis associated with the use of biological glue.
2001-05
Urea permeation and hydrolysis through hollow fiber dialyzer immobilized with urease.
2001-05
Enzyme conjugation to the polysaccharide chitosan: smart biocatalysts and biocatalytic hydrogels.
2001-04-21
Biological cells as templates for hollow microcapsules.
2001-04-20
Saphenous vein endothelial cell viability: a comparative study of endoscopic and open saphenectomy for coronary artery bypass grafting.
2001-04-17
Aneurysmal dilation of a pericardial patch prepared with glutharaldehyde and used for closure of a ventricular septal defect.
2001-04
Characterization of UV-irradiated dense/porous collagen membranes: morphology, enzymatic degradation, and mechanical properties.
2001-04
Improved methods for examination of Toxoplasma gondii cytoskeleton at ultrastructural level.
2001-04
Ultrastructure of Achilles tendon from rats after treatment with fleroxacin.
2001-04
Glutaraldehyde-induced colitis.
2001-04
Histopathologic analysis of endovascular stent grafts from patients with aortic aneurysms: Does healing occur?
2001-04
AIA (American Institute of Architects) 2001 guidelines and indoor air health.
2001-04
Dental hygienists and infection control: knowledge, attitudes and behaviour in Italy.
2001-04
Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture.
2001-04
Refolding of Taiwan cobra neurotoxin: intramolecular cross-link affects its refolding reaction.
2001-03-15
Detection of hepatopancreatic parvovirus (HPV) of penaeid shrimp by in situ hybridization at the electron microscope level.
2001-03-09
Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes.
2001-03-01
Detection of complement C1-inhibitor with a piezoelectric immunosensor.
2001-03
Characteristics of silicon nitride after O2 plasma surface treatment for pH-ISFET applications.
2001-03
Electron microscopic cytochemical studies of anionic sites in the rat spleen.
2001-03
The influence of ventricular input impedance on the hydrodynamic performance of bioprosthetic aortic roots in vitro.
2001-03
Monovalent cation-induced conformational change in glucose oxidase leading to stabilization of the enzyme.
2001-02-20
Patch reconstruction of the mitral annulus for active infective endocarditis with annular abscess.
2001-02
Improving the activity of immobilized subtilisin by site-directed attachment through a genetically engineered affinity tag.
2001-02
Crystal structure of the complex of concanavalin A and tripeptide.
2001-01
Cellular mechanism of calcification and its prevention in glutaraldehyde treated vascular tissue.
2001
Purification and characterization of catalase from chard (Beta vulgaris var. cicla).
2001
Controlled release of growth factors based on biodegradation of gelatin hydrogel.
2001
Normal embryonic stages of the longnose gar, Lepisosteus osseus.
2001
One hundred consecutive treatments with holmium: YAG laser for pulmonary bullae: especially in conjunction with gelatin-resorcinol formaldehyde-glutaraldehyde glue adhesion.
2001
Three-dimensional reconstruction by scanning electron microscopy from serial epoxy resin semi-thin sections after ion-etching.
2001
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:50:06 GMT 2025
Edited
by admin
on Mon Mar 31 17:50:06 GMT 2025
Record UNII
T3C89M417N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLUTARAL
HSDB   INCI   INN   JAN   MART.   USAN   USP   WHO-DD  
INN   INCI   USAN  
Official Name English
GLUTARALDEHYDE
FCC   MI   VANDF  
Preferred Name English
GLUTARALDEHYDE [FCC]
Common Name English
NSC-13392
Code English
GLUTARIC ACID DIALDEHYDE
Common Name English
GLUTARAL [MART.]
Common Name English
SONACIDE
Brand Name English
Pentanedial
Systematic Name English
GLUTARALDEHYDE [MI]
Common Name English
1,5-PENTANEDIAL
Systematic Name English
STERIHYDE L
Brand Name English
GLUTARAL [JAN]
Common Name English
GLUTARAL [USAN]
Common Name English
glutaral [INN]
Common Name English
GLUTARAL [HSDB]
Common Name English
GLUTARAL [USP IMPURITY]
Common Name English
GLUTARAL CONCENTRATE [USP MONOGRAPH]
Common Name English
GLUTARALDEHYDE [VANDF]
Common Name English
Glutaral [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ESSENTIAL MEDICINES LIST 15.2
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
CFR 21 CFR 172.230
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
EPA PESTICIDE CODE 43901
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
CFR 21 CFR 173.320
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
CFR 21 CFR 176.170
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
Code System Code Type Description
SMS_ID
100000092538
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
MESH
D005976
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
HSDB
949
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
CONCEPT Industrial Aid
FDA UNII
T3C89M417N
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
NSC
13392
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
DRUG BANK
DB03266
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
NCI_THESAURUS
C80930
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
DRUG CENTRAL
3267
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
CFR
21 CFR 176.300
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
INN
3417
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
RXCUI
4888
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
GLUTARALDEHYDE
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
PUBCHEM
3485
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
ChEMBL
CHEMBL1235482
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
DAILYMED
T3C89M417N
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
EPA CompTox
DTXSID6025355
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
CAS
111-30-8
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
ECHA (EC/EINECS)
203-856-5
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
EVMPD
SUB07943MIG
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
CHEBI
64276
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY
MERCK INDEX
m5778
Created by admin on Mon Mar 31 17:50:06 GMT 2025 , Edited by admin on Mon Mar 31 17:50:06 GMT 2025
PRIMARY Merck Index
Related Record Type Details
ACTIVE MOIETY